Shares in Inovio Pharmaceuticals (NSDQ:INO) rose today after the pharmaceutical company beat expectations on Wall Street with its second quarter results.
The Plymouth Meeting, Penn.-based company posted a net loss of -$9.5 million on sales of $20.4 million for the 3 months ended June 30, for bottom-line growth of 49% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Inovio tops Q2 sales estimate by $4m appeared first on MassDevice.
from MassDevice http://ift.tt/2vk4SXC
Cap comentari:
Publica un comentari a l'entrada